| 價(jià)格 | 詢價(jià) |
| 包裝 | 1removed |
| 最小起訂量 | 1removed |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-04-02 |
| 中文名稱:化合物 Org 27569 | 英文名稱:Org 27569 |
| CAS:868273-06-7 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號: T001|T2635 |
| 名稱 | Org 27569 |
| 描述 | Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and enhanced agonist affinity. |
| 細(xì)胞實(shí)驗(yàn) | Cells expressing CB1 receptors are exposed to ORG27569 (10 μM) for 5 to 15 min. For toxin treatment to abrogate Gi coupling effects, PTX is added to the medium at 5 ng/ml. Following an 18-h incubation in the presence of toxin, cells are washed twice with PBS and treated with compounds. Cells are washed with ice-cold PBS, and cell lysates are obtained by harvesting the cells with ice-cold lysis buffer (150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris, pH 7.5 containing 4-(2-aminoethyl)benzenesulfonyl fluoride, pepstatin A, E-64, bestatin, leupeptin, and aprotinin as protease inhibitors).(Only for Reference) |
| 激酶實(shí)驗(yàn) | Equilibrium Binding Assays.: Binding assays are performed with the CB1 receptor agonist [3H]CP 55,940 (0.7 nM) and the CB1 receptor antagonist [3H]SR 141716A (1.2 nM), 1 mg/ml BSA and 50 mM Tris buffer containing 0.1 mM EDTA and 0.5 mM MgCl2, pH 7.4, in a total assay volume of 500 μl. Binding is initiated by the addition of mouse brain membranes (30 μg). Assays are carried out at 37°C for 60 min before termination by addition of ice-cold wash buffer (50 mM Tris buffer and 1 mg/ml BSA) and vacuum filtration using a 24-well sampling manifold and Whatman GF/B glass-fiber filters that have been soaked in wash buffer at 4°C for 24 h. Each reaction tube is washed five times with a 4-ml aliquot of buffer. The filters are oven-dried for 60 min and then placed in 5 ml of scintillation fluid, and radioactivity is quantitated by liquid scintillation spectrometry. Specific binding is defined as the difference between the binding that occurred in the presence and absence of 1 μM concentrations of the corresponding unlabeled ligand and is 70 to 80% of the total binding. |
| 體內(nèi)活性 | ORG 27569 (3.2 和 5.6 mg/kg, i.p.) 顯著抑制了大鼠[4]的可卡因相關(guān)提示誘發(fā)再啟動、可卡因啟動誘發(fā)再啟動、甲基苯丙胺相關(guān)提示誘發(fā)再啟動以及甲基苯丙胺啟動誘發(fā)再啟動。Org27569 (30 mg/kg, i.p.) 產(chǎn)生了CB1非依賴性的抑食效應(yīng),并且不影響阿納米特(AEA)的鑒別刺激效應(yīng)。Org27569(100 μg腦室內(nèi))與載體相比,不影響系統(tǒng)性給予CP55,940的藥理效應(yīng)[5]。 |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+90% Corn Oil : 2 mg/mL (4.88 mM), Sonication is recommended. DMSO : 41 mg/mL (100.01 mM), Sonication is recommended. |
| 關(guān)鍵字 | Org-27569 | Org27569 | Org 27569 | Inhibitor | inhibit | CB1 | CB | CannabinoidReceptor | Cannabinoid Receptor |
| 相關(guān)產(chǎn)品 | Drinabant | AM281 | CB1 inverse agonist 1 | CB2 receptor agonist 2 | β-Caryophyllene | AM-1235 | Pregnenolone acetate | 2,3-Butanediol | CB1 antagonist 2 | Pregnenolone | CB2 modulator 1 | RTICBM-189 |
| 相關(guān)庫 | 經(jīng)典已知活性庫 | 抗癌化合物庫 | 已知活性化合物庫 | 線粒體靶向庫 | 神經(jīng)遞質(zhì)受體化合物庫 | 神經(jīng)信號分子庫 | 抗COVID-19化合物庫 | 抗肥胖化合物庫 | GPCR靶點(diǎn)分子庫 | 神經(jīng)退行性疾病化合物庫 | 膜蛋白靶向化合物庫 | 表型篩選靶點(diǎn)鑒定庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-04-22 | |
| 詢價(jià) |
VIP4年
|
陜西西化化學(xué)工業(yè)有限公司
|
2026-05-25 | |
| 詢價(jià) |
VIP8年
|
廣州市桐暉藥業(yè)有限公司
|
2026-06-02 | |
| ¥544.90 |
VIP14年
|
上海阿拉丁生化科技股份有限公司
|
2026-05-14 |